All News about Biora Therapeutics, Inc. - Common Stock
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces Reverse Stock Split
December 30, 2022
Via GlobeNewswire
Looking Into Biora Therapeutics's Return On Invested Capital
December 27, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/16/image-adobe.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8445.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/21/image_5.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image13.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image_3.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/08/image16.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/image14.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces $9.75 Million Direct Offering
November 07, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
October 27, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18400.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/29/image30_0.jpeg?width=1200&height=800&fit=crop)
Why Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket
September 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3054.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_4609.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14477.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/74f7c790-2ce7-4964-8bc9-9a41f6818600/small/biora-tm-rgb-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_8404.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8423.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/11/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/10/image_4_1.jpg?width=1200&height=800&fit=crop)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free